Amyl Therapeutics SRL
Records under this name other than the patents Amyl Therapeutics SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 2 of 2 · Back to Amyl Therapeutics SRL
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,692,017 | General amyloid interaction motif (GAIM) Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,988,444 | Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity Lapsed on the fee record Ended Jun 5, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 5, 2026 | USPTO record |